To test a method to quantify adherence of medication use to clinical guideline recommendations in a primary care setting. (Abstracts from the ESCP 36th European Symposium on Clinical Pharmacy 'Implementing Clinical Pharmacy in Community and Hospital Settings: Sharing the Experience', Istanbul, Turkey 25-27 October 2007; published in 'Pharmacy World and Science': http://www.springerlink.com/content/b4u765154t051245/fulltext.pdf
ESCP 7th spring conference on clinical pharmacy, tackling inequalities in the delivery of pharmaceut...
Cardiovascular disease (CVD) accounts for 18% of disease burden in Australia, and 35% of deaths. Evi...
BACKGROUND Cardiovascular disease (CVD) is the major cause of death worldwide. Although effective...
To test a method to quantify adherence of medication use to clinical guideline recommendations in a ...
ESCP 7th spring conference on clinical pharmacy, tackling inequalities in the delivery of pharmaceut...
Cardiovascular diseases are estimated to cause 46% of all mortalities in Kuwait. The aim of evidence...
Medication assessment tools (MATs) may be implemented in routine electronic data sources in order to...
<p>Background Medication assessment tools (MATs) may be implemented in routine electronic data sourc...
Background Medication assessment tools (MATs) may be implemented in routine electronic data sources ...
The study aimed to assess adherence of prescribed medication in primary care to nationally recognise...
Cardiovascular diseases have become the single leading cause of death and disease burden globally in...
ESCP 7th spring conference on clinical pharmacy, tackling inequalities in the delivery of pharmaceut...
Cardiovascular disease (CVD) accounts for 18% of disease burden in Australia, and 35% of deaths. Evi...
BACKGROUND Cardiovascular disease (CVD) is the major cause of death worldwide. Although effective...
To test a method to quantify adherence of medication use to clinical guideline recommendations in a ...
ESCP 7th spring conference on clinical pharmacy, tackling inequalities in the delivery of pharmaceut...
Cardiovascular diseases are estimated to cause 46% of all mortalities in Kuwait. The aim of evidence...
Medication assessment tools (MATs) may be implemented in routine electronic data sources in order to...
<p>Background Medication assessment tools (MATs) may be implemented in routine electronic data sourc...
Background Medication assessment tools (MATs) may be implemented in routine electronic data sources ...
The study aimed to assess adherence of prescribed medication in primary care to nationally recognise...
Cardiovascular diseases have become the single leading cause of death and disease burden globally in...
ESCP 7th spring conference on clinical pharmacy, tackling inequalities in the delivery of pharmaceut...
Cardiovascular disease (CVD) accounts for 18% of disease burden in Australia, and 35% of deaths. Evi...
BACKGROUND Cardiovascular disease (CVD) is the major cause of death worldwide. Although effective...